Your session is about to expire
← Back to Search
Brachytherapy
IORT for Glioblastoma Recurrence
N/A
Waitlist Available
Led By David A Wiles, MD
Research Sponsored by Parkridge Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years.
Awards & highlights
Summary
This trial assesses whether a new, single-fraction radiation treatment is as good as the standard radiation treatment for people with a type of brain cancer that has come back.
Eligible Conditions
- Glioblastoma Multiforme (GBM)
- Glioblastoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medical Devices
The primary endpoint is Overall Survival (OS)
Secondary outcome measures
Karnofsky Performance Status (KPS)
Local Progression-free Survival (PFS)
Quality of Life Assessment (Fact-Br)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Intra-operative Radiation Therapy - IORTExperimental Treatment1 Intervention
Intra-operative Radiation Therapy - IORT
Find a Location
Who is running the clinical trial?
Parkridge Medical CenterLead Sponsor
David A Wiles, MDPrincipal InvestigatorParkridge Medical Center - Neurosurgery
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have tumors located too close to important parts of the brain, like the Optic Chiasm and Optic Nerve, making it difficult to safely deliver enough treatment to the tumor.You have received radiation treatment for a type of brain tumor called GBM less than 3 months ago.You have experienced more than three instances of the condition coming back after treatment.You have cancer that has spread to multiple parts of your body.
Research Study Groups:
This trial has the following groups:- Group 1: Intra-operative Radiation Therapy - IORT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger